The comparison of RTX treated versus untreated matched-control SSc patients from the EUSTAR cohort demonstrated improvement of skin fibrosis and prevention of worsening lung fibrosis. PubMed, Ann Rheum Dis, 2015 Jun;74(6):1188-94. (Also see Biologic Agents)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.